Physician profile
David J Park
NPI 1457518722
$18,294.83
in general payments reported to CMS, 2019-2025
17 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $317 · 2021: $676 · 2022: $635 · 2024: $462 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,964.00 |
| Food and Beverage | $1,234.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $14,964.00 | 2025 | |
| Abbott Laboratories | $797.87 | 2019-2022 | |
| Boston Scientific Corporation | $527.16 | 2019-2025 | Avvigo Guidance System |
| Medtronic, INC. | $349.06 | 2021-2025 | Linq II |
| Astellas Pharma US INC | $271.97 | 2020-2022 | |
| Amgen INC. | $179.28 | 2024-2025 | Repatha |
| Cvrx, INC. | $167.45 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $150.37 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.89 | 2024 | Lifevest |
| Recor Medical INC | $119.33 | 2025 | Paradise Ultrasound Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $119.05 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $101.73 | 2025 | Caldolor |
| E.R. Squibb & Sons, L.L.C. | $96.42 | 2024 | Camzyos |
| Scpharmaceuticals INC. | $95.96 | 2024 | |
| Janssen Pharmaceuticals, INC | $88.15 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $85.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.79 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.